These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 15857996)
1. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996 [TBL] [Abstract][Full Text] [Related]
2. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. Stremlau M; Perron M; Welikala S; Sodroski J J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033 [TBL] [Abstract][Full Text] [Related]
3. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. Ohkura S; Yap MW; Sheldon T; Stoye JP J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305 [TBL] [Abstract][Full Text] [Related]
4. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314 [TBL] [Abstract][Full Text] [Related]
5. Evolution of TRIM5alpha B30.2 (SPRY) domain in New World primates. Soares EA; Menezes AN; Schrago CG; Moreira MA; Bonvicino CR; Soares MA; Seuánez HN Infect Genet Evol; 2010 Mar; 10(2):246-53. PubMed ID: 19931648 [TBL] [Abstract][Full Text] [Related]
6. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha. Perron MJ; Stremlau M; Sodroski J J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044 [TBL] [Abstract][Full Text] [Related]
7. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha. Li X; Song B; Xiang SH; Sodroski J Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365 [TBL] [Abstract][Full Text] [Related]
8. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395 [TBL] [Abstract][Full Text] [Related]
9. The control of viral infection by tripartite motif proteins and cyclophilin A. Towers GJ Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686 [TBL] [Abstract][Full Text] [Related]
10. Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? Rhodes DA; de Bono B; Trowsdale J Immunology; 2005 Dec; 116(4):411-7. PubMed ID: 16313355 [TBL] [Abstract][Full Text] [Related]
11. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains. Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307 [TBL] [Abstract][Full Text] [Related]
12. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. Sawyer SL; Emerman M; Malik HS PLoS Pathog; 2007 Dec; 3(12):e197. PubMed ID: 18159944 [TBL] [Abstract][Full Text] [Related]
13. Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. McEwan WA; Schaller T; Ylinen LM; Hosie MJ; Towers GJ; Willett BJ J Virol; 2009 Aug; 83(16):8270-5. PubMed ID: 19494015 [TBL] [Abstract][Full Text] [Related]
14. Identification of a genomic reservoir for new TRIM genes in primate genomes. Han K; Lou DI; Sawyer SL PLoS Genet; 2011 Dec; 7(12):e1002388. PubMed ID: 22144910 [TBL] [Abstract][Full Text] [Related]
15. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. Nakayama EE; Miyoshi H; Nagai Y; Shioda T J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780 [TBL] [Abstract][Full Text] [Related]
16. Control of viral infectivity by tripartite motif proteins. Towers GJ Hum Gene Ther; 2005 Oct; 16(10):1125-32. PubMed ID: 16218773 [TBL] [Abstract][Full Text] [Related]
17. Unique features of TRIM5alpha among closely related human TRIM family members. Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811 [TBL] [Abstract][Full Text] [Related]
18. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. Li X; Sodroski J J Virol; 2008 Dec; 82(23):11495-502. PubMed ID: 18799578 [TBL] [Abstract][Full Text] [Related]
19. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685 [TBL] [Abstract][Full Text] [Related]
20. TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity. Spada SJ; Grigg ME; Bouamr F; Best SM; Zhang P Viruses; 2024 Jun; 16(7):. PubMed ID: 39066160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]